Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0000950170-25-082472

Director acquired 21,130 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BAKER BROS. ADVISORS LP Director 2025-06-03 Grant or award +10,565 336,867 I
BAKER BROS. ADVISORS LP Director 2025-06-03 Grant or award +10,565 3,415,958 I
Derivatives
BAKER BROS. ADVISORS LP Director 2025-06-03 Grant or award · Non-Qualified Stock Option (right to buy)uy) +31,695 31,695 I
BAKER BROS. ADVISORS LP Director 2025-06-03 Grant or award · Non- Qualified Stock Option (right to buy) +31,695 31,695 I
Loading xslF345X05/ownership.xml…